Kevin K. Ariën
Kevin K. Ariën
Professor of Virology, Institute of Tropical Medicine, Antwerp, Belgium
E-mail confirmado em itg.be
Título
Citado por
Citado por
Ano
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates
KK Ariën, A Abraha, ME Quinones-Mateu, L Kestens, G Vanham, EJ Arts
Journal of virology 79 (14), 8979-8990, 2005
2502005
Is HIV-1 evolving to a less virulent form in humans?
KK Ariën, G Vanham, EJ Arts
Nature Reviews Microbiology 5 (2), 141-151, 2007
2402007
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time
KK Ariën, RM Troyer, Y Gali, RL Colebunders, EJ Arts, G Vanham
Aids 19 (15), 1555-1564, 2005
942005
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time
KK Ariën, RM Troyer, Y Gali, RL Colebunders, EJ Arts, G Vanham
Aids 19 (15), 1555-1564, 2005
942005
The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
HF Njai, Y Gali, G Vanham, C Clybergh, W Jennes, N Vidal, C Butel, ...
Retrovirology 3 (1), 1-11, 2006
922006
Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine
J das Neves, J Michiels, KK Ariën, G Vanham, M Amiji, MF Bahia, ...
Pharmaceutical research 29 (6), 1468-1484, 2012
772012
HIV Nef: role in pathogenesis and viral fitness
KK Arien, B Verhasselt
Current HIV research 6 (3), 200-208, 2008
732008
In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides
Y Gali, O Delezay, J Brouwers, N Addad, P Augustijns, T Bourlet, ...
Antimicrobial agents and chemotherapy 54 (12), 5105-5114, 2010
722010
Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women
JK Kyongo, V Jespers, O Goovaerts, J Michiels, J Menten, RN Fichorova, ...
PloS one 7 (8), e43951, 2012
622012
In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the Anti-HIV Drug Dapivirine
J das Neves, F Araújo, F Andrade, J Michiels, KK Ariën, G Vanham, ...
Molecular pharmaceutics 10 (7), 2793-2807, 2013
602013
Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention
JK Kyongo, T Crucitti, J Menten, L Hardy, P Cools, J Michiels, ...
Clinical and Vaccine Immunology 22 (5), 526-538, 2015
592015
HIV sexual transmission and microbicides
KK Ariën, V Jespers, G Vanham
Reviews in medical virology 21 (2), 110-133, 2011
552011
The HIV-1 transmission bottleneck
SM Kariuki, P Selhorst, KK Ariën, JR Dorfman
Retrovirology 14 (1), 1-19, 2017
442017
Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones
KK Ariën, Y Gali, A El-Abdellati, L Heyndrickx, W Janssens, G Vanham
Virology 347 (1), 65-74, 2006
442006
Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort
Y Gali, B Berkhout, G Vanham, M Bakker, NKT Back, KK Ariën
Virology 364 (1), 140-146, 2007
432007
Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity
Y Gali, KK Ariën, M Praet, R Van den Bergh, M Temmerman, O Delezay, ...
Journal of virological methods 165 (2), 186-197, 2010
422010
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides
P Selhorst, AC Vazquez, K Terrazas-Aranda, J Michiels, K Vereecken, ...
Antimicrobial agents and chemotherapy 55 (4), 1403-1413, 2011
372011
Dengue vaccine: reliably determining previous exposure
KK Ariën, A Wilder-Smith
The Lancet Global Health 6 (8), e830-e831, 2018
302018
Letter to the editor: Specificity of Zika virus ELISA: interference with malaria
M Van Esbroeck, K Meersman, J Michiels, KK Ariën, D Van den Bossche
Eurosurveillance 21 (21), 30237, 2016
252016
Confirmed Zika virus infection in a Belgian traveler returning from Guatemala, and the diagnostic challenges of imported cases into Europe
B De Smet, D Van den Bossche, C van de Werve, J Mairesse, ...
Journal of Clinical Virology 80, 8-11, 2016
242016
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20